Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1ZRO

Crystal structure of EBA-175 Region II (RII) crystallized in the presence of (alpha)2,3-sialyllactose

Summary for 1ZRO
Entry DOI10.2210/pdb1zro/pdb
Related1ZRL
Descriptorerythrocyte binding antigen region II, SULFATE ION, CHLORIDE ION, ... (4 entities in total)
Functional Keywordseba-175, rii, dbl, erythrocyte, invasion, host, malaria, disease, glycophorin, glycan, sialic acid, sialyllactose, cell invasion
Biological sourcePlasmodium falciparum (malaria parasite P. falciparum)
Total number of polymer chains2
Total formula weight146047.60
Authors
Tolia, N.H.,Enemark, E.J.,Sim, B.K.,Joshua-Tor, L. (deposition date: 2005-05-19, release date: 2005-08-09, Last modification date: 2024-11-06)
Primary citationTolia, N.H.,Enemark, E.J.,Sim, B.K.,Joshua-Tor, L.
Structural Basis for the EBA-175 Erythrocyte Invasion Pathway of the Malaria Parasite Plasmodium falciparum.
Cell(Cambridge,Mass.), 122:183-193, 2005
Cited by
PubMed Abstract: Erythrocyte binding antigen 175 (EBA-175) is a P. falciparum protein that binds the major glycoprotein found on human erythrocytes, glycophorin A, during invasion. Here we present the crystal structure of the erythrocyte binding domain of EBA-175, RII, which has been established as a vaccine candidate. Binding sites for the heavily sialylated receptor glycophorin A are proposed based on a complex of RII with a glycan that contains the essential components required for binding. The dimeric organization of RII displays two prominent channels that contain four of the six observed glycan binding sites. Each monomer consists of two Duffy binding-like (DBL) domains (F1 and F2). F2 more prominently lines the channels and makes the majority of the glycan contacts, underscoring its role in cytoadherence and in antigenic variation in malaria. Our studies provide insight into the mechanism of erythrocyte invasion by the malaria parasite and aid in rational drug design and vaccines.
PubMed: 16051144
DOI: 10.1016/j.cell.2005.05.033
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.25 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon